A global community of scientists and clinicians committed to fast-tracking ME/CFS research


Under the guidance of our scientific advisory board director, world-renowned geneticist Ronald W. Davis, PhD, Open Medicine Foundation (OMF) has brought together expert scientists and clinicians for a bold international collaborative research project coined “The End ME/CFS Project.”

The goal for this project is to develop a diagnostic tool, deliver treatments, and ultimately find a cure for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS).

Using my expertise in clinical systems biology in the fields of medicine, genomics, proteomics, and computational biology, I hope to establish a new paradigm for how ME/CFS is understood, diagnosed, managed and treated.

Ronald W. Davis, PhD
Stanford University


A vital part of The End ME/CFS Project is to financially support goal-directed research centers that work collaboratively with each other and the global research community of scientists and clinicians. The strategy is to constantly remain focused on fast-tracking research so that diagnosis, treatments, and a cure can be available to patients as soon as possible. This method of funding a research network ensures the persistence of a long-term, committed, and multi-pronged research initiative.

We Need Your Support

Millions are needed annually to support The End ME/CFS Project. OMF and OMFCA have set an aggressive goal to raise $20+ million per year from grants and donations. Join the campaign to end Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) by donating, ask your friends, family, and peers to give to the ground-breaking research.

These initiatives stand to impact millions whose lives have been overturned by ME/CFS.

Ronald G. Tompkins, MD, ScD
Harvard Medical School

The Research Centres

OMF has funded the launch of three Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Collaborative Research Centeres. The centres and their working groups are building a repository of data using a series of innovative analytical techniques and multi-omics platforms (genomics, proteomics, metabolomics, transcriptomics). Currently, this data is informing the development of diagnostic technologies, hypotheses of the underlying cause of the disease, and potential treatments to trial. OMFCA is supporting the Centres at Stanford and Harvard Universities. 

OMF-Established Collaborative Research Centres


Ronald W. Davis, PhD

Innovative, collaborative, open-data
research to end ME/CFS


Ronald G. Tompkins, MD, ScD  and Wenzhong Xiao, PhD

Clinical and scientific mechanistic studies to understand ME/CFS and discover new treatments

Centre Researchers and Working Group​
Ronald W. Davis, PhD
Laurel Crosby, PhD

Mark M. Davis, PhD
Mike Snyder, PhD
Wenzhong Xiao, PhD
Craig Heller, PhD
Lars Steinmetz, PhD
Fereshteh Jahaniani, PhD
Mohsen Nemat-Gorgani, PhD
Peidong Shen, PhD
Amit Saha, PhD
Eric Shaqfeh, PhD
Juan Santiago, PhD
Gozde Durmus, PhD
Julie Wilhelmy
William Robinson, MD
Curt Scharfe, MD
David Kaufman, MD


Rahim Esfandyarpour, PhD

Uppsala University, Sweden

Jonas Bergquist, MD, PhD,
Kumari Ubhayasekhera, PhD
Annie Bynke
Rizwan Muhammad
Torsten Gordh, MD, PhD

Massachusetts General Hospital

Ronald G. Tompkins, MD, ScD
Wenzhong Xiao, PhD
Donna Felsenstein, MD
Jonathan Friedstat, MD
Daniel Irimia, MD, PhD
Amel Karaa, MD
Michael VanElzakker, PhD
H. Shaw Warren, MD
Yongming Yu, MD, PhD
Andrew Alexander, MBA


Anand Ramasubramanian, PhD


Robert Phair, PhD


Maureen Hanson, PhD

Open Medicine Foundation

Linda Tannenbaum
Christopher Armstrong, PhD

Brigham & Women’s Hospital

Anthony Komaroff, MD
David Systrom, MD

Beth Israel Deaconess Medical Center

Janet Mullington, PhD

University of Birmingham, UK

Janet Lord, PhD

Philip Atherton, PhD
Paul Greenhaff, PhD

Pacific Northwest National Laboratory

Richard Smith, PhD
Jon Jacob, PhD
Wei-Jun Qian, PhD